6:01 PM ET
Earnings Call
▶ Call
BridgeBio Pharma Earnings Call: Key Takeaways
BridgeBio is transitioning to a multi-product commercial stage company with $253.2M in Acaramidus revenue and three major FDA PDUFA dates scheduled within the next seven months.
- Call
- Oct 29, 2026, 4:30 PM ET